You are not currently logged in.
Access JSTOR through your library or other institution:
If You Use a Screen ReaderThis content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
An Essential Regulatory Role for Macrophage Migration Inhibitory Factor in T-Cell Activation
Michael Bacher, Christine N. Metz, Thierry Calandra, Katrin Mayer, Jason Chesney, Michael Lohoff, Diethard Gemsa, Thomas Donnelly and Richard Bucala
Proceedings of the National Academy of Sciences of the United States of America
Vol. 93, No. 15 (Jul. 23, 1996), pp. 7849-7854
Published by: National Academy of Sciences
Stable URL: http://www.jstor.org/stable/40125
Page Count: 6
You can always find the topics here!Topics: T lymphocytes, Antibodies, Glucocorticoids, Cultured cells, Macrophages, Cytokines, Antigen presenting cells, Messenger RNA, Immunology, Enzyme linked immunosorbent assay
Were these topics helpful?See somethings inaccurate? Let us know!
Select the topics that are inaccurate.
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Preview not available
The protein known as macrophage migration inhibitory factor (MIF) was one of the first cytokines to be discovered and was described 30 years ago to be a T-cell-derived factor that inhibited the random migration of macrophages in vitro. A much broader role for MIF has emerged recently as a result of studies that have demonstrated it to be released from the anterior pituitary gland in vivo. MIF also is the first protein that has been identified to be secreted from monocytes/macrophages upon glucocorticoid stimulation. Once released, MIF acts to ``override'' or counter-regulate the suppressive effects of glucocorticoids on macrophage cytokine production. We report herein that MIF plays an important regulatory role in the activation of T cells induced by mitogenic or antigenic stimuli. Activated T cells produce MIF and neutralizing anti-MIF antibodies inhibit T-cell proliferation and interleukin 2 production in vitro, and suppress antigen-driven T-cell activation and antibody production in vivo. T cells also release MIF in response to glucocorticoid stimulation and MIF acts to override glucocorticoid inhibition of T-cell proliferation and interleukin 2 and interferon γ production. These studies indicate that MIF acts in concert with glucocorticoids to control T-cell activation and assign a previously unsuspected but critical role for MIF in antigenspecific immune responses.
Proceedings of the National Academy of Sciences of the United States of America © 1996 National Academy of Sciences